Literature DB >> 23193059

Are companion diagnostics useful?

J Carl Barrett1, Melanie M Frigault, Simon Hollingsworth, Glenn A Miller, Vijay Modur.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23193059     DOI： 10.1373/clinchem.2012.185132

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

1.  Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine.

Authors:  Gregory S Zaric
Journal:  Pharmacoeconomics       Date:  2016-07       Impact factor: 4.981

2.  Molecular tumor board: the University of California-San Diego Moores Cancer Center experience.

Authors:  Maria Schwaederle; Barbara A Parker; Richard B Schwab; Paul T Fanta; Sarah G Boles; Gregory A Daniels; Lyudmila A Bazhenova; Rupa Subramanian; Alice C Coutinho; Haydee Ojeda-Fournier; Brian Datnow; Nicholas J Webster; Scott M Lippman; Razelle Kurzrock
Journal:  Oncologist       Date:  2014-05-05

Review 3.  Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.

Authors:  Maria Schwaederle; Melissa Zhao; J Jack Lee; Alexander M Eggermont; Richard L Schilsky; John Mendelsohn; Vladimir Lazar; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

4.  Report from the OECI Oncology Days 2014.

Authors:  Wh van Harten; G Stanta; G Bussolati; P Riegman; G Hoefler; Kf Becker; G Folprecht; M Truini; J Haybaeck; R Buiga; M Dono; A Bagg; Ja López Guerrero; S Zupo; F Lemare; F de Lorenzo; N Goedbloed; D Razavi; J Lövey; Pa Cadariu; Ga Rollandi; F Paparo; M Pierotti; T Ciuleanu; P De Paoli; G Weiner; M Saghatchian; Claudio Lombardo
Journal:  Ecancermedicalscience       Date:  2014-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.